Baseline characteristics of participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Hypertension

Volumn 37, Issue 1, 2001, Pages 19-27

  Grimm Jr, Richard H ^a   Margolis, Karen L ^a   Papademetriou, Vasilios ^b   Cushman, William C ^c   Ford, Charles E ^d   Bettencourt, Judy ^d   Alderman, Michael H ^e   Basile, Jan N ^f   Black, Henry R ^g   DeQuattro, Vincent ^h   Eckfeldt, John ⁱ   Hawkins, C Morton ^d   Perry Jr, H Mitchell ^j   Proschan, Michael ^k  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h LAC USC MEDICAL CENTER   (United States)

ⁱ UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^j VETERANS AFFAIRS MEDICAL CENTER   (United States)

^k NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

Antihypertensive agents; Clinical trials; Diuretics; Hypertension, essential; Lipids

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; CALCIUM ANTAGONIST; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; LISINOPRIL;

ADULT; AGED; ARTICLE; CANADA; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; ETHNIC GROUP; FEMALE; GENDER; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PUERTO RICO; RACE; RANDOMIZED CONTROLLED TRIAL; SMOKING; UNITED STATES; VIRGIN ISLANDS (U.S.);

EID: 0035156493     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.37.1.19     Document Type: Article

References (28)

1. Prevalence of hypertension in the US adult population
2. Blood pressure, stroke, and coronary heart disease, 2: Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
3. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
4. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
5. Medical Research Council trial of treatment of hypertension in older adults: Principal results
6. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
7. Clinical clues to magnesium deficiency
8. Antihypertensive agents, serum lipoproteins and glucose metabolism
9. Health outcomes associated with antihypertensive therapies used as first-line agents: A systematic review and meta-analysis
10. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and morality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
11. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
12. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies
13. Should calcium antagonists be first line drugs in hypertension?
14. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
15. Outcome results of the Fosinopril versus Amlodipine Cardiovascular Events randomized Trial (FACET) in patients with hypertension and NIDDM
16. Effect of amlodipine on morbidity and mortality in severe chronic heart failure
17. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients
18. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
19. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
20. Single-drug therapy for hypertension in men
21. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: Results of the HANE study
22. Treatment of Mild Hypertension Study final results
23. Randomised trial of old and new hypertensive drugs in elderly patients: Cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with hypertension-2 study
24. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to prevent Heart Attack Trial (ALLHAT)
25. Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone
26. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
27. End-stage renal disease in African-American and white men: 16-Year MRFIT findings
28. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular events in high-risk patients